Human testing of the first anti-nicotine vaccine has begun, according to
British drugs company Xenova. Medical director John Roberts says the drug could
help people quit because it prevents nicotine acting on the brain and so stops
addiction. Nicotine patches or gum simply substitute inhaled nicotine with a
more benign form. The vaccine will work best for smokers who risk relapsing
after quitting. The vaccine will stop a lapse of will power “sending you back to
the beginning of the craving cycle�, says Roberts.
More from New Ä¢¹½Ö±²¥
Explore the latest news, articles and features
Health
Woman entered hibernation-like state during winter for more than 30 years
News
Health
Cooking pollution dominates air quality at mealtimes in London
News
Life
Otherworldly image of a porcelain crab wins ocean photography contest
Regulars
Comment
The 28 best popular science books of 2026
Culture
Popular articles
Trending New Ä¢¹½Ö±²¥ articles